Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Genmab Stock Popped on Friday


Before the market open on the last trading day of the week, two analysts tracking (NASDAQ: GMAB) stock felt compelled to raise their price targets on the biotech. This double-barreled blast of bullishness pushed the company's shares more than 4% higher that trading session, easily beating the essentially stagnant S 500 (SNPINDEX: ^GSPC).

Not surprisingly, both lifts were based largely on Genmab's latest acquisition. On Tuesday, the company announced it struck a deal to acquire Dutch peer Merus in a purchase valued at $8 billion.

Image source: Getty Images.

Continue reading


Source Fool.com

Genmab A/S Stock

€270.40
1.200%
There is an upward development for Genmab A/S compared to yesterday, with an increase of €3.20 (1.200%).

Like: 0
Share

Comments